Parvovirus B19 is the causative agent of a variety of clinical manifes
tations, ranging from asymptomatic to severe infection, The basis for
this complex pattern of B19-associated diseases is as yet poorly under
stood. In general there are two different possibilities: firstly, the
infected individuals may have a genetic or acquired predisposition, wh
ich renders them susceptible for a certain course of infection; second
ly, differences in the B19 genome may result in different outcomes of
infection, In order to investigate this second possibility we have par
tially sequenced the genomes of 20 different B19 isolates derived from
serum samples from patients with various B19-associated diseases. Fou
r distinct regions, which cover nearly half of the genome and include
parts of the coding regions of all three major B19 proteins - NS1, VP1
and VP2, were selected for sequencing. Comparisons between the differ
ent extracted virus isolates at the DNA and protein levels revealed th
at isolates from patients with persistent parvovirus B19 infection sho
w a tendency towards higher genome variability with respect to isolate
s derived from persons with acute infection.